Table 1 Demographic, clinical and laboratory data according to residual renal function
From: Can residual kidney function affect quality of life and cognitive function in hemodialysis patients?
RKF (yes) n = 29 (≥100 mL/day) | RKF (No) n = 49 (> 100 ml/day) | P | |
|---|---|---|---|
Demographic and clinical data | |||
Age (years) | 45 (33–63) | 57 (42–65) | 0.127 |
Gender / male | 16 (55.2%) | 30 (61.2) | 0.599 |
Diabetes mellitus | 3 (10.3%) | 7 (14.3%) | 0.736 |
Hypertension | 26 (89.7%) | 39 (79.6%) | 0.351 |
Original kidney disease: | 0.39 | ||
Hypertensive nephrosclerosis | 11 (37.9%) | 22 (44.9%) | |
Diabetic nephropathy | 3 (10.3%) | 6 (12.2%) | |
Polycystic kidney disease | 0 | 2 (4.1%) | |
Obstructive uropathy | 0 | 3 (6.1%) | |
Hereditary | 0 | 2 (4.1%) | |
Reflux nephropathy | 1 (3.4%) | 0 | |
Lupus nephritis | 2 (6.9%) | 0 | |
Chronic glomerulonephritis | 1 (3.4%) | 0 | |
Failed kidney transplant | 0 | 1 (2%) | |
Chronic interstitial nephritis | 4 (13.8%) | 0 | |
Unknown | 6 (20.7%) | 13 (26.5%) | |
Drug-induced | 1 (3.4%) | 0 | |
HCV positivity | 1 (3.4%) | 15 (30.6%) | 0.004 |
Parathyroidectomy | 0 | 3 (6.1%) | NA |
HD duration (years) | 2 (1.5–3) | 6 (4–8) | < 0.001 |
BMI (Kg/m2) | 30.1 (24.9–34.4) | 27.1 (24.9–32.9) | 0.22 |
Laboratory data | |||
Hemoglobin (g/dl) | 10.6 (9.45–11.5) | 10.7 (9.9–11.8) | 0.498 |
TSAT (%) | 28 (21–38.5) | 31 (22.5–39.5) | 0.441 |
Ferritin (ng/ml) | 543 (285–927) | 552 (315–1037.5) | 0.714 |
Calcium (mg/dl) | 8.8 (8–9.19) | 8.8 (7.85–9.19) | 0.796 |
Phosphorus (mg/dl) | 5.7689 ± 2.0651 | 5.6326 ± 1.79691 | 0.760 |
PTH (pg/ml) | 483 (277.5–884.5) | 736 (379.5–1047.5) | 0.141 |
KT/V | 1.1547 (0.8567–1.3402) | 1.2563 (0.86–1.6301) | 0.329 |